Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Suggested Search Criteria

Enter extra filters to help narrow your search

Search

Type in a keyword to search

Filter by records added date
See new records

Options


Current Facets and Filters

  • References:pmid:26589293 (facet)

Facets


Recent searches

Snippet view Table view
Click the to add this resource to an Authentication Report or Collection

1,197 Results - per page

Show More Columns | Download Top 1000 Results

Name Proper Citation Organism Disease Comments Defining Citation Category Sex Synonyms Vendor Catalog Number Cross References Hierarchy Originate from Same Individual ID Record Last Update Mentions Count
IMR-32
 
Resource Report
Resource Website
100+ mentions
Discontinued
Possibly Discontinued
KCLB Cat# 10127, RRID:CVCL_0346 Homo sapiens (Human) Neuroblastoma Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:62055
PMID:71759
PMID:327080
PMID:833871
PMID:856461
PMID:922665
PMID:2535691
PMID:3518877
PMID:3698005
PMID:5459762
PMID:6401685
PMID:6888561
PMID:6935474
PMID:7037175
PMID:7139592
PMID:7253718
PMID:7459858
PMID:7838528
PMID:8221663
PMID:8490657
PMID:8665486
PMID:9201287
PMID:9283597
PMID:9516836
PMID:11550280
PMID:11668190
PMID:12210830
PMID:12702577
PMID:15390183
PMID:15892104
PMID:16524757
PMID:16822308
PMID:17974978
PMID:20655465
PMID:22213050
PMID:22460905
PMID:24466371
PMID:25485619
PMID:25877200
PMID:25894527
PMID:26589293
PMID:28350380
PMID:30894373
PMID:31068700
PMID:31581737
PMID:33460449
Cancer cell line Male IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 KCLB 10127 BTO:BTO_0000934,
CLO:CLO_0006948,
CLO:CLO_0016777,
EFO:EFO_0001195,
MCCL:MCC:0000242,
CLDB:cl2878,
CLDB:cl2879,
CLDB:cl2880,
CLDB:cl2881,
CLDB:cl2882,
CLDB:cl2883,
CLDB:cl2885,
CLDB:cl2886,
CLDB:cl2887,
CLDB:cl2888,
ABM:T8975,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:CCL-127,
BCRC:60014,
BCRJ:0377,
BioGRID_ORCS_Cell_line:637,
BioSample:SAMN00808348,
BioSample:SAMN03472412,
BioSample:SAMN03473082,
BioSample:SAMN10988103,
cancercelllines:CVCL_0346,
CCRID:1101HUM-PUMC000282,
CCRID:3101HUMTCHu145,
CCRID:4201HUM-CCTCC00107,
CCTCC:GDC0107,
Cell_Model_Passport:SIDM00226,
CGH-DB:78-1,
CGH-DB:9095-4,
ChEMBL-Cells:CHEMBL3307656,
ChEMBL-Targets:CHEMBL614585,
CLS:300148,
Coriell:AG03320,
Coriell:GM03320,
Cosmic:688067,
Cosmic:759892,
Cosmic:801746,
Cosmic:920239,
Cosmic:922658,
Cosmic:947702,
Cosmic:1019944,
Cosmic:1037352,
Cosmic:1099149,
Cosmic:1109111,
Cosmic:1237544,
Cosmic:1518066,
Cosmic:1526626,
Cosmic:2058113,
Cosmic:2131590,
Cosmic:2301580,
Cosmic:2393630,
Cosmic:2485944,
DepMap:ACH-000310,
DSMZ:ACC-165,
DSMZCellDive:ACC-165,
ECACC:86041809,
EGA:EGAS00001000610,
GEO:GSM453632,
GEO:GSM563362,
GEO:GSM692859,
GEO:GSM887162,
GEO:GSM888234,
GEO:GSM1366406,
GEO:GSM1669934,
GEO:GSM2371237,
GEO:GSM2394364,
IARC_TP53:23585,
ICLC:HTL96021,
IZSLER:BS TCL 29,
JCRB:IFO50283,
JCRB:JCRB9050,
KCB:KCB 2011100YJ,
KCLB:10127,
LiGeA:CCLE_016,
LINCS_LDP:LCL-1965,
Lonza:971,
PharmacoDB:IMR32_659_2019,
PRIDE:PXD000589,
Progenetix:CVCL_0346,
PubChem_Cell_line:CVCL_0346,
RCB:RCB1895,
TKG:TKG 0207,
Wikidata:Q54897618
CVCL_0346 2026-09-19 05:41:59 353
HBL-100
 
Resource Report
Resource Website
1+ mentions
Misidentified
Discontinued
Discontinued
RCB Cat# RCB0460, RRID:CVCL_4362 Homo sapiens (Human) Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124)., Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.. PMID:2547730
PMID:2840847
PMID:2995096
PMID:3109929
PMID:6500159
PMID:6891286
PMID:9671407
PMID:10969801
PMID:11416159
PMID:12661003
PMID:16643607
PMID:17157791
PMID:20143388
PMID:24094812
PMID:24176112
PMID:25485619
PMID:25877200
PMID:26589293
PMID:28889351
Transformed cell line Male HBL 100, HBL100 RCB RCB0460 BTO:BTO_0004734,
CLO:CLO_0003626,
EFO:EFO_0001167,
CLDB:cl1571,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-TABM-157,
ATCC:HTB-124,
BioSample:SAMN03152011,
BioSample:SAMN03471101,
BioSample:SAMN03472914,
CCRID:1101HUM-PUMC000374,
CCRID:3101HUMGNHu10,
CCTCC:GDC0195,
ChEMBL-Cells:CHEMBL3307713,
ChEMBL-Targets:CHEMBL614811,
CLS:300178,
Cosmic:687471,
Cosmic:877447,
Cosmic:934533,
Cosmic:979722,
Cosmic:991323,
Cosmic:1010933,
Cosmic:1136364,
Cosmic:1176632,
Cosmic:1434949,
Cosmic:1524348,
Cosmic:1609469,
DepMap:ACH-002321,
EGA:EGAS00001000610,
GEO:GSM1053697,
IARC_TP53:21063,
LINCS_HMS:51117,
PharmacoDB:HBL100_443_2019,
PubChem_Cell_line:CVCL_4362,
RCB:RCB0460,
TOKU-E:3589,
Ubigene:YC-C013,
Wikidata:Q54881428
CVCL_4362 2026-09-19 05:35:13 2
HBL-100
 
Resource Report
Resource Website
1+ mentions
Misidentified
Discontinued
Discontinued
CCTCC Cat# GDC0195, RRID:CVCL_4362 Homo sapiens (Human) Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124)., Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.. PMID:2547730
PMID:2840847
PMID:2995096
PMID:3109929
PMID:6500159
PMID:6891286
PMID:9671407
PMID:10969801
PMID:11416159
PMID:12661003
PMID:16643607
PMID:17157791
PMID:20143388
PMID:24094812
PMID:24176112
PMID:25485619
PMID:25877200
PMID:26589293
PMID:28889351
Transformed cell line Male HBL 100, HBL100 CCTCC GDC0195 BTO:BTO_0004734,
CLO:CLO_0003626,
EFO:EFO_0001167,
CLDB:cl1571,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-TABM-157,
ATCC:HTB-124,
BioSample:SAMN03152011,
BioSample:SAMN03471101,
BioSample:SAMN03472914,
CCRID:1101HUM-PUMC000374,
CCRID:3101HUMGNHu10,
CCTCC:GDC0195,
ChEMBL-Cells:CHEMBL3307713,
ChEMBL-Targets:CHEMBL614811,
CLS:300178,
Cosmic:687471,
Cosmic:877447,
Cosmic:934533,
Cosmic:979722,
Cosmic:991323,
Cosmic:1010933,
Cosmic:1136364,
Cosmic:1176632,
Cosmic:1434949,
Cosmic:1524348,
Cosmic:1609469,
DepMap:ACH-002321,
EGA:EGAS00001000610,
GEO:GSM1053697,
IARC_TP53:21063,
LINCS_HMS:51117,
PharmacoDB:HBL100_443_2019,
PubChem_Cell_line:CVCL_4362,
RCB:RCB0460,
TOKU-E:3589,
Ubigene:YC-C013,
Wikidata:Q54881428
CVCL_4362 2026-09-19 05:35:13 2
HCA7
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_0289 Homo sapiens (Human) Colon adenocarcinoma Part of: KuDOS 95 cell line panel. PMID:3718830
PMID:4016751
PMID:8410493
PMID:8464898
PMID:9294210
PMID:10737795
PMID:11226274
PMID:16418264
PMID:18258742
PMID:20570890
PMID:20606684
PMID:24755471
PMID:25485619
PMID:25877200
PMID:25926053
PMID:26589293
PMID:29101300
Cancer cell line Female HCA-7, HCA 7 BTO:BTO_0003031,
EFO:EFO_0006415,
MCCL:MCC:0000179,
AddexBio:C0009003/40,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03471988,
cancercelllines:CVCL_0289,
ColonAtlas:HCA7,
Cosmic:876722,
Cosmic:948860,
Cosmic:985995,
Cosmic:995407,
Cosmic:1043813,
Cosmic:1223140,
Cosmic:1312301,
Cosmic:1479629,
Cosmic:1486131,
Cosmic:1805252,
Cosmic:1933017,
Cosmic:2301976,
Cosmic:2760084,
ECACC:06061902,
EGA:EGAS00001000610,
GEO:GSM741260,
GEO:GSM1346872,
GEO:GSM1374491,
GEO:GSM1374492,
GEO:GSM1448125,
GEO:GSM3145609,
GEO:GSM3145708,
IARC_TP53:21760,
PharmacoDB:HCA7_445_2019,
PRIDE:PXD005354,
PRIDE:PXD005355,
Wikidata:Q54881491,
Ximbio:152451
CVCL_0289 2026-09-19 05:35:15 4
HMCB
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_3317 Homo sapiens (Human) Melanoma Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma., Anecdotal: The Bowes cell line is famous for its use in the identification and purification of tissue-type plasminogen activator, tPA., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line. PMID:1970678
PMID:12068308
PMID:20215515
PMID:22460905
PMID:26589293
PMID:30894373
PMID:31068700
Cancer cell line Female Human Melanoma Cell Bowes, Bowes melanoma cells, BOWES BTO:BTO_0001998,
CLO:CLO_0003785,
EFO:EFO_0002195,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-9607,
BioSample:SAMN10988240,
cancercelllines:CVCL_3317,
Cell_Model_Passport:SIDM00914,
ChEMBL-Cells:CHEMBL3308385,
ChEMBL-Targets:CHEMBL614824,
Cosmic:724822,
DepMap:ACH-000931,
GEO:GSM827473,
GEO:GSM887087,
GEO:GSM888157,
IARC_TP53:21374,
IGRhCellID:HMCB,
LiGeA:CCLE_295,
NCBI_Iran:C524,
PharmacoDB:HMCB_553_2019,
Progenetix:CVCL_3317,
PubChem_Cell_line:CVCL_3317,
Wikidata:Q54889913
CVCL_3317 2026-09-19 05:38:02 9
HOP-62
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_1285 Homo sapiens (Human) Lung adenocarcinoma Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:2041050
PMID:2388294
PMID:2536293
PMID:9331090
PMID:10700174
PMID:12068308
PMID:15748285
PMID:17088437
PMID:19372543
PMID:20164919
PMID:22068913
PMID:22347499
PMID:22384151
PMID:22628656
PMID:22961666
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28196595
PMID:29681454
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:35839778
PMID:38861359
Cancer cell line Female HOP 62, Hop 62, HOP.62, HOP62, Hop62, Hopkins-62 BTO:BTO_0004080,
CLO:CLO_0037016,
EFO:EFO_0006439,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:418,
BioSample:SAMN03471402,
BioSample:SAMN10989587,
cancercelllines:CVCL_1285,
Cell_Model_Passport:SIDM00133,
ChEMBL-Cells:CHEMBL3307671,
ChEMBL-Targets:CHEMBL614643,
Cosmic:875855,
Cosmic:905972,
Cosmic:974289,
Cosmic:1092603,
Cosmic:1146945,
Cosmic:1175861,
Cosmic:1305344,
Cosmic:1995442,
Cosmic:1998445,
Cosmic-CLP:905972,
DepMap:ACH-000861,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905972,
GEO:GSM2105,
GEO:GSM50211,
GEO:GSM50274,
GEO:GSM206507,
GEO:GSM274784,
GEO:GSM274816,
GEO:GSM434275,
GEO:GSM743450,
GEO:GSM750804,
GEO:GSM794404,
GEO:GSM799338,
GEO:GSM799401,
GEO:GSM846357,
GEO:GSM1153408,
GEO:GSM1178204,
GEO:GSM1178205,
GEO:GSM1178206,
GEO:GSM1181256,
GEO:GSM1181314,
GEO:GSM1374542,
GEO:GSM2124640,
IARC_TP53:21113,
IGRhCellID:HOP-62_02GEO,
LiGeA:CCLE_548,
LINCS_LDP:LCL-1666,
NCI-DTP:HOP-62,
PharmacoDB:HOP62_561_2019,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1285,
PubChem_Cell_line:CVCL_1285,
SKY/M-FISH/CGH:2896,
Wikidata:Q54890155
CVCL_1285 2026-09-19 05:38:07 11
HPAF-II
 
Resource Report
Resource Website
50+ mentions
RRID:CVCL_0313 Homo sapiens (Human) Pancreatic ductal adenocarcinoma Caution: TP53 mutation indicated incorrectly as being at c.452C>T in PubMed=1764370., Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:1764370
PMID:2734279
PMID:11787853
PMID:12068308
PMID:12692724
PMID:15126341
PMID:15367885
PMID:15367897
PMID:18380791
PMID:20164919
PMID:20215515
PMID:20418756
PMID:22460905
PMID:22585861
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26216984
PMID:26589293
PMID:27259358
PMID:27397505
PMID:28196595
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31037374
PMID:31068700
Cancer cell line Male HPAF II, HPAFII, HPAF-2, HPAF2, HPAF/CD18, CD18/HPAF, HPAF-II/CD18, CD-18, CD18, CD 18 BTO:BTO_0003266,
CLO:CLO_0003816,
EFO:EFO_0002198,
MCCL:MCC:0000206,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1997,
BioGRID_ORCS_Cell_line:236,
BioSample:SAMN03471950,
BioSample:SAMN10987875,
cancercelllines:CVCL_0313,
CCRID:3101HUMSCSP5011,
Cell_Model_Passport:SIDM00669,
CGH-DB:165-1,
CGH-DB:9274-4,
ChEMBL-Cells:CHEMBL3308744,
ChEMBL-Targets:CHEMBL1075467,
CLS:305088,
Cosmic:710858,
Cosmic:724869,
Cosmic:868241,
Cosmic:913304,
Cosmic:922247,
Cosmic:1108343,
Cosmic:1299299,
Cosmic:1320467,
Cosmic:1571777,
Cosmic:2046534,
Cosmic:2434099,
Cosmic-CLP:724869,
DepMap:ACH-000094,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:724869,
GEO:GSM206510,
GEO:GSM385517,
GEO:GSM385528,
GEO:GSM621899,
GEO:GSM784696,
GEO:GSM827289,
GEO:GSM887090,
GEO:GSM888161,
GEO:GSM1024402,
GEO:GSM1374546,
GEO:GSM1374547,
GEO:GSM1669893,
IARC_TP53:944,
IGRhCellID:HPAFII,
IZSLER:BS TCL 170,
LiGeA:CCLE_028,
LINCS_LDP:LCL-1736,
MetaboLights:MTBLS812,
PharmacoDB:HPAFII_565_2019,
PRIDE:PXD003198,
Progenetix:CVCL_0313,
PubChem_Cell_line:CVCL_0313,
TOKU-E:4028,
Wikidata:Q54890231
cvcl_b284 CVCL_0313 2026-09-19 05:38:09 71
HPB-ALL
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_1820 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia Population: Japanese., Part of: LL-100 blood cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:203546
PMID:1373528
PMID:2140233
PMID:2985879
PMID:3159941
PMID:3874327
PMID:6181032
PMID:6582512
PMID:6749281
PMID:8127147
PMID:8641406
PMID:8957066
PMID:9510473
PMID:9738977
PMID:9933131
PMID:10739008
PMID:11226526
PMID:12661009
PMID:15472075
PMID:16142349
PMID:17170727
PMID:22460905
PMID:22675565
PMID:26589293
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:35354797
Cancer cell line Male HPB/ALL, HPBALL, FCCH1018 BTO:BTO_0001952,
CLO:CLO_0003817,
CLO:CLO_0050988,
EFO:EFO_0022458,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioSample:SAMN01821632,
BioSample:SAMN03473562,
BioSample:SAMN10988462,
cancercelllines:CVCL_1820,
Cell_Model_Passport:SIDM01618,
ChEMBL-Cells:CHEMBL4295419,
ChEMBL-Targets:CHEMBL4296435,
Cosmic:801726,
Cosmic:913406,
Cosmic:919159,
Cosmic:933550,
Cosmic:998736,
Cosmic:999754,
Cosmic:1037689,
Cosmic:1115583,
Cosmic:1130235,
Cosmic:1151779,
Cosmic:1224373,
Cosmic:1281368,
Cosmic:1330499,
Cosmic:1524796,
Cosmic:1641378,
Cosmic:1664521,
Cosmic:1760522,
Cosmic:2165711,
Cosmic:2602914,
DepMap:ACH-000942,
DSMZ:ACC-483,
DSMZCellDive:ACC-483,
FANTOM5_SSTAR:10429-106D6,
GEO:GSM887091,
GEO:GSM888162,
GEO:GSM5137717,
IARC_TP53:21703,
LiGeA:CCLE_898,
Lonza:250,
NCBI_Iran:C213,
PharmacoDB:HPBALL_566_2019,
PRIDE:PXD023662,
Progenetix:CVCL_1820,
PubChem_Cell_line:CVCL_1820,
RCB:RCB1935,
TKG:TKG 0199,
Wikidata:Q54890235
CVCL_1820 2026-09-19 05:38:09 7
HL-60
 
Resource Report
Resource Website
1000+ mentions
Discontinued
RRID:CVCL_0002 Homo sapiens (Human) Adult acute myeloid leukemia with maturation Anecdotal: Established at the 60th attempt to culture human leukemia biopsies in Gallo's lab. All the preceding attempts having failed., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Biotechnology: Used a source of mitochondrial DNA for USA forensic testing., Population: Caucasian., Part of: MYC genetic alteration cell panel (ATCC TCP-1035)., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut). PMID:271272
PMID:288488
PMID:1368402
PMID:1574572
PMID:1970118
PMID:2140233
PMID:2545346
PMID:2858093
PMID:2985879
PMID:3159941
PMID:3311197
PMID:3335022
PMID:3422031
PMID:3860286
PMID:3874327
PMID:6091813
PMID:6255959
PMID:6582512
PMID:6945469
PMID:6954533
PMID:6996765
PMID:7630190
PMID:8316623
PMID:8343448
PMID:8558913
PMID:8562479
PMID:9434637
PMID:9510473
PMID:9557624
PMID:9607592
PMID:9737686
PMID:9738977
PMID:10739008
PMID:11226526
PMID:11416159
PMID:12068308
PMID:12661003
PMID:15843827
PMID:16120335
PMID:16408098
PMID:16957166
PMID:17088437
PMID:20164919
PMID:20215515
PMID:22032829
PMID:22068913
PMID:22347499
PMID:22460905
PMID:22944676
PMID:23955599
PMID:24368162
PMID:24670534
PMID:25485619
PMID:25877200
PMID:25894527
PMID:25984343
PMID:26589293
PMID:27397505
PMID:28109323
PMID:28196595
PMID:29491412
PMID:30285677
PMID:30629668
PMID:30670178
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31733513
PMID:33389257
PMID:35839778
PMID:36982453
Cancer cell line Female HL 60, HL.60, HL60, Human Leukemia-60 BTO:BTO_0000738,
CLO:CLO_0003775,
CLO:CLO_0050972,
EFO:EFO_0002793,
MCCL:MCC:0000195,
CLDB:cl1682,
CLDB:cl1684,
CLDB:cl1685,
CLDB:cl1686,
CLDB:cl1687,
CLDB:cl1688,
CLDB:cl1689,
CLDB:cl1690,
CLDB:cl1691,
CLDB:cl1693,
Abcam:ab282204,
AddexBio:C0003023/4977,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ATCC:CCL-240,
BCRC:60027,
BCRJ:0104,
BioGRID_ORCS_Cell_line:42,
BioSample:SAMN01821559,
BioSample:SAMN01821682,
BioSample:SAMN03472768,
BioSample:SAMN03473174,
BioSample:SAMN10988245,
cancercelllines:CVCL_0002,
CCRID:1101HUM-PUMC000037,
CCRID:1102HUM-NIFDC00098,
CCRID:3101HUMTCHu23,
CCRID:4201HUM-CCTCC00028,
CCTCC:GDC0027,
CCTCC:GDC0028,
Cell_Model_Passport:SIDM00829,
ChEMBL-Cells:CHEMBL3307654,
ChEMBL-Targets:CHEMBL383,
CLS:300209,
Cosmic:716179,
Cosmic:716190,
Cosmic:724817,
Cosmic:787433,
Cosmic:798224,
Cosmic:798665,
Cosmic:808506,
Cosmic:821043,
Cosmic:850380,
Cosmic:851996,
Cosmic:875866,
Cosmic:905938,
Cosmic:919116,
Cosmic:922161,
Cosmic:922683,
Cosmic:924049,
Cosmic:932769,
Cosmic:947366,
Cosmic:949099,
Cosmic:975252,
Cosmic:981578,
Cosmic:991557,
Cosmic:994170,
Cosmic:999724,
Cosmic:1012068,
Cosmic:1019836,
Cosmic:1037661,
Cosmic:1070693,
Cosmic:1078724,
Cosmic:1089519,
Cosmic:1092602,
Cosmic:1107177,
Cosmic:1127250,
Cosmic:1130234,
Cosmic:1168468,
Cosmic:1176580,
Cosmic:1181599,
Cosmic:1191695,
Cosmic:1192826,
Cosmic:1226863,
Cosmic:1281315,
Cosmic:1305337,
Cosmic:1308224,
Cosmic:1319549,
Cosmic:1451845,
Cosmic:1465966,
Cosmic:1523825,
Cosmic:1524830,
Cosmic:1582390,
Cosmic:1601062,
Cosmic:1604861,
Cosmic:1998444,
Cosmic:2036678,
Cosmic:2089652,
Cosmic:2131539,
Cosmic:2301565,
Cosmic:2306208,
Cosmic:2651387,
Cosmic-CLP:905938,
DepMap:ACH-000002,
DSMZ:ACC-3,
DSMZCellDive:ACC-3,
ECACC:98070106,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS069ENC,
ENCODE:ENCBS070ENC,
ENCODE:ENCBS215JQI,
ENCODE:ENCBS308XSW,
ENCODE:ENCBS373UEY,
ENCODE:ENCBS482VCU,
ENCODE:ENCBS698WLF,
ENCODE:ENCBS869DKF,
ENCODE:ENCBS880XNW,
FANTOM5_SSTAR:10829-111D1,
GDSC:905938,
GEO:GSM50194,
GEO:GSM50258,
GEO:GSM213809,
GEO:GSM236782,
GEO:GSM236818,
GEO:GSM472908,
GEO:GSM472942,
GEO:GSM482507,
GEO:GSM545496,
GEO:GSM545497,
GEO:GSM743458,
GEO:GSM749688,
GEO:GSM749775,
GEO:GSM750812,
GEO:GSM799346,
GEO:GSM799409,
GEO:GSM838428,
GEO:GSM838429,
GEO:GSM838430,
GEO:GSM838431,
GEO:GSM887083,
GEO:GSM888153,
GEO:GSM945222,
GEO:GSM945255,
GEO:GSM1153417,
GEO:GSM1181331,
GEO:GSM1181348,
GEO:GSM1374535,
GEO:GSM1374536,
GEO:GSM1446736,
GEO:GSM1669883,
GEO:GSM2716740,
GEO:GSM2716741,
GEO:GSM2716742,
GEO:GSM2716743,
GEO:GSM7701378,
GEO:GSM7701379,
IARC_TP53:21372,
IARC_TP53:21731,
ICLC:HTL95010,
IGRhCellID:HL60,
IZSLER:BS TCL 25,
JCRB:IFO50022,
JCRB:JCRB0085,
JCRB:NIHS0086,
KCB:KCB 2014051YJ,
KCLB:10240,
LiGeA:CCLE_789,
LINCS_LDP:LCL-1054,
Lonza:64,
MeSH:D018922,
NCBI_Iran:C217,
PharmacoDB:HL60_546_2019,
PRIDE:PRD000345,
PRIDE:PXD000589,
PRIDE:PXD003539,
PRIDE:PXD006421,
PRIDE:PXD030304,
PRIDE:PXD032942,
Progenetix:CVCL_0002,
PubChem_Cell_line:CVCL_0002,
RCB:RCB0041,
RCB:RCB3683,
SKY/M-FISH/CGH:5609,
TKG:TKG 0345,
TOKU-E:1488,
Ubigene:YC-C058,
Wikidata:Q5630035
CVCL_0002 2026-09-19 05:37:59 4410
HLF
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_2947 Homo sapiens (Human) Adult hepatocellular carcinoma Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:52570
PMID:1778766
PMID:7874267
PMID:8389256
PMID:9290701
PMID:10523694
PMID:12029633
PMID:15767549
PMID:22460905
PMID:23505090
PMID:23887712
PMID:25984343
PMID:26589293
PMID:28196595
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
PMID:31978347
PMID:32899426
Cancer cell line Male CLO:CLO_0009987,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:657,
BioSample:SAMN10987769,
cancercelllines:CVCL_2947,
Cell_Model_Passport:SIDM00065,
CGH-DB:9076-4,
Cosmic:945157,
Cosmic:1187332,
Cosmic:1518229,
Cosmic:2023860,
Cosmic:2162527,
DepMap:ACH-000393,
GEO:GSM887086,
GEO:GSM888156,
GEO:GSM936758,
GEO:GSM1374538,
GEO:GSM1669885,
GEO:GSM2551567,
IARC_TP53:2009,
JCRB:JCRB0405,
LiGeA:CCLE_520,
LIMORE:HLF,
LINCS_HMS:50015,
LINCS_LDP:LCL-1938,
PharmacoDB:HLF_549_2019,
Progenetix:CVCL_2947,
Wikidata:Q54889850
CVCL_2947 2026-09-19 05:38:00 14
HGC-27
 
Resource Report
Resource Website
500+ mentions
RRID:CVCL_1279 Homo sapiens (Human) Gastric carcinoma Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:136873
PMID:3986962
PMID:11314020
PMID:11416159
PMID:15767549
PMID:15901131
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24807215
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:34466148
PMID:35839778
Cancer cell line Sex unspecified HGC 27, HGC27 BTO:BTO_0004828,
CLO:CLO_0003739,
CLO:CLO_0050799,
EFO:EFO_0006581,
CLDB:cl1673,
CLDB:cl1674,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BCRJ:0310,
BioGRID_ORCS_Cell_line:658,
BioSample:SAMN03472940,
BioSample:SAMN10987863,
cancercelllines:CVCL_1279,
CCRID:1101HUM-PUMC000279,
CCRID:3101HUMTCHu22,
CCRID:5301HUM-KCB16001YJ,
Cell_Model_Passport:SIDM00290,
ChEMBL-Cells:CHEMBL3308741,
ChEMBL-Targets:CHEMBL1075463,
CLS:300436,
Cosmic:907055,
Cosmic:1001653,
Cosmic:1007604,
Cosmic:1187274,
Cosmic:1518247,
Cosmic:1995440,
Cosmic:2484952,
Cosmic:2807625,
Cosmic-CLP:907055,
DepMap:ACH-000847,
ECACC:94042256,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907055,
GEO:GSM552358,
GEO:GSM827366,
GEO:GSM844558,
GEO:GSM887081,
GEO:GSM888151,
GEO:GSM1374533,
GEO:GSM1374534,
GEO:GSM1669881,
GEO:GSM2983069,
GEO:GSM2983070,
GEO:GSM2983071,
GEO:GSM2983072,
IARC_TP53:21370,
ICLC:HTL95028,
KCB:KCB 2016001YJ,
LiGeA:CCLE_106,
LINCS_LDP:LCL-1882,
PharmacoDB:HGC27_543_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1279,
PubChem_Cell_line:CVCL_1279,
RCB:RCB0500,
Ubigene:YC-C079,
Wikidata:Q54886004
CVCL_1279 2026-09-19 05:37:28 586
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
IZSLER Cat# BS TCL 23, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 IZSLER BS TCL 23 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
ATCC Cat# CCL-23, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 ATCC CCL-23 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
ECACC Cat# 86030501, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 ECACC 86030501 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
KCLB Cat# 10023, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 KCLB 10023 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
CCLV Cat# CCLV-RIE 0141, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 CCLV CCLV-RIE 0141 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
BCRC Cat# 60042, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 BCRC 60042 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
BCRJ Cat# 0101, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 BCRJ 0101 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
CCTCC Cat# GDC0004, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 CCTCC GDC0004 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737
cvcl_0030 CVCL_1906 2026-09-19 05:35:50 2898
HEY
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_0297 Homo sapiens (Human) High grade ovarian serous adenocarcinoma Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:3731068
PMID:4016745
PMID:12960427
PMID:19926575
PMID:20204287
PMID:22710073
PMID:23415752
PMID:24023729
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30485824
PMID:30894373
PMID:30971826
PMID:35839778
Cancer cell line Female Hey BTO:BTO_0002590,
EFO:EFO_0006580,
MCCL:MCC:0000188,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:866,
BioSample:SAMN03473280,
cancercelllines:CVCL_0297,
Cell_Model_Passport:SIDM00968,
ChEMBL-Cells:CHEMBL3308082,
ChEMBL-Targets:CHEMBL613869,
CLS:305017,
Cosmic:1102812,
Cosmic:1524358,
Cosmic-CLP:1479988,
DepMap:ACH-002140,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1479988,
GEO:GSM659377,
GEO:GSM1340581,
GEO:GSM1669880,
IARC_TP53:28489,
PharmacoDB:HEY_541_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_0297,
Wikidata:Q54883211
cvcl_4995 CVCL_0297 2026-09-19 05:36:06 23

Can't find your Cell Line?

We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.

If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.

Can't find the RRID you're searching for? X
X
  1. Neuroscience Information Framework Resources

    Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.